Found 68 matching trials
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer PHASE2 Rectal cancer still remains one of the most popular tumors, however, distan...
Show More Location
Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences,
Learn More & Join Trial
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. PHASE2 This prospective, multi-center, phase II randomized controlled trial will e...
Show More Location
Johannes Gutenberg-University Clinic, Mainz, Germany 1.Dept. Medicine, Prof. Peter R. Galle
Learn More & Join Trial
Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer NA Rectal cancer represents the most complex area of multidisciplinary treatme...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. PHASE2 This study hypothesizes that approximately 50% of rectal cancer patients ca...
Show More Location
Nacional Cancer Institute
Learn More & Join Trial
Total Neoadjuvant Therapy With Additional Consolidation Chemotherapy Followed by Local Excision Versus Total Neoadjuvant Therapy Followed by Local Excision at Stage I Rectal Cancer NA Safety and Efficacy of Organ Preservation Treatment for Stage I Rectal Canc...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer NA This is a prospective multicenter randomized controlled trial study. Accord...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer NA The SHAPERS study is a multicentre, open-label, randomised, pragmatic clini...
Show More Learn More & Join Trial
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen PHASE2 This study is designed to test the efficacy and safety of Total Neoadjuvant...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer PHASE2 The addition of durvalumab to total neoadjuvant therapy (TNT) in locally ad...
Show More Learn More & Join Trial
RAPIDO vs LCRT vs Upfront Surgery - a Prospective Cohort Study N/A Aim: We evaluated the surgical outcomes of 3 groups of patients with rectal...
Show More Location
Multiple Locations
Learn More & Join Trial